Müller A, Machnik F, Zimmermann T, Schubert H
Department of Internal Medicine, Freidrich Schiller University, Jena, DDR.
Exp Pathol. 1988;34(4):229-36. doi: 10.1016/s0232-1513(88)80155-5.
Long term administration of thioacetamide (0.03% in tap water) results in a characteristic lesion in rat liver, which corresponds to cirrhosis-like patterns of micronodular cirrhosis type after treatment over 3 months. During its development a reproducible temporal course of biochemical and morphological changes can be recognized. After withdrawal of the toxic agent this lesion persists for about 2 months. Then the cirrhosis-like alterations recede and a proliferation of bile ducts predominates, which is associated with increasing portal fibrosis altering the pattern and relatively enhancing the total collagen content of the liver. Considering these peculiarities, the TAA-model is suitable for investigations into connective tissue metabolism in the fibrotic liver and cirrhosis-like patterns. Search for and test of therapeutic principles should be done during TAA-administration (prophylactic agents) or within 2 months after withdrawal of toxic agents (therapeutics).
长期给予硫代乙酰胺(自来水中含0.03%)会导致大鼠肝脏出现特征性病变,在治疗3个月后,该病变对应于微小结节性肝硬化类型的肝硬化样模式。在其发展过程中,可以识别出生化和形态学变化的可重复时间进程。停用毒性剂后,这种病变会持续约2个月。然后,肝硬化样改变消退,胆管增生占主导,这与门静脉纤维化增加有关,从而改变了肝脏的模式并相对增加了肝脏的总胶原蛋白含量。考虑到这些特点,硫代乙酰胺模型适用于研究纤维化肝脏中的结缔组织代谢和肝硬化样模式。治疗原则的寻找和测试应在给予硫代乙酰胺期间(预防剂)或停用毒性剂后2个月内(治疗剂)进行。